You are here

gene editing

A serious new hurdle for CRISPR: Edited cells might cause cancer, find two studies

A serious new hurdle for CRISPR: Edited cells might cause cancer, find two studies

Stat

Flag link:

Gene Editing Pioneers Launch Beam Therapeutics With $87 Million Series A Round

Gene Editing Pioneers Launch Beam Therapeutics With $87 Million Series A Round

CP Wire

Beam Therapeutics

Flag link:

Gene editing shows promise in combating HIV reservoirs

Gene editing shows promise in combating HIV reservoirs

Fierce Biotech

Flag link:

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys

MIT Technology Review

clinical trials

Flag link:

No Data Yet, But Homology Upsizes IPO and Raises $144M

No Data Yet, But Homology Upsizes IPO and Raises $144M

Xconomy

Flag link:

[video]Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important

[video]Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important

Motley Fool

Sangamo Therapeutics

Flag link:

Startup making Cas9 proxy for gene editing gets $55M to develop tools/software

Startup making Cas9 proxy for gene editing gets $55M to develop tools/software

Endpoints

Flag link:

Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost

Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost

Xconomy

Gilead Sciences

Flag link:

Sarepta is making a bold bet on genetic medicine

Sarepta is making a bold bet on genetic medicine

Marketwatch

Sarepta Therapeutics

genetic medicine

Flag link:

Disruptor Alert: These 5 Companies Are Changing Healthcare

Disruptor Alert: These 5 Companies Are Changing Healthcare

Motley Fool

CRISPR Therapeutics

Editas Medicine

Intellia Therapeutics

gene sequencing

artificial intelligence

Flag link:

Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech

Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech

Endpoints

Hunter Syndrome

Flag link:

Anti-CRISPR Proteins Could Improve Accuracy of Gene Editing

Anti-CRISPR Proteins Could Improve Accuracy of Gene Editing

Xtalks

anti-CRISPR proteins

Flag link:

5 Trends affecting gene therapy development

5 Trends affecting gene therapy development

BioPharma Dive

drug development

Flag link:

'The Biggest Biotech Discovery Of The Century'

'The Biggest Biotech Discovery Of The Century'

Seeking Alpha

Flag link:

Gene editing star CRISPR Therapeutics files for $90M IPO

Gene editing star CRISPR Therapeutics files for $90M IPO

Endpoints

CRISPR Therapeutics

Flag link:

Do CRISPR enthusiasts have their head in the sand about the safety of gene editing?

Do CRISPR enthusiasts have their head in the sand about the safety of gene editing?

Stat

Flag link:

Startup biotech Homology Med aims to 'leapfrog' CRISPR competitors

Startup biotech Homology Med aims to 'leapfrog' CRISPR competitors

BioPharma Dive

Flag link:

Biogen plans to launch gene therapy and gene editing collaboration with University of Pennsylvania

Biogen plans to launch gene therapy and gene editing collaboration with University of Pennsylvania

Marketwatch

Flag link:

Gene editing biotech Homology Med launches with $44 million in financing

Gene editing biotech Homology Med launches with $44 million in financing

BioPharma Dive

Flag link:

Controversial CRISPR history sets off an online firestorm

Controversial CRISPR history sets off an online firestorm

Stat

Flag link:

Pages